Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
134M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
8.74M
-
Shares change
-
+1.5M
-
Total reported value, excl. options
-
$39.6M
-
Value change
-
+$7.48M
-
Put/Call ratio
-
2.06
-
Number of buys
-
16
-
Number of sells
-
-15
-
Price
-
$4.53
Significant Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q1 2021
40 filings reported holding CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share as of Q1 2021.
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.74M shares
of 134M outstanding shares and own 6.53% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (3.57M shares), Oasis Management Co Ltd. (1.82M shares), Man Group plc (1.38M shares), Quinn Opportunity Partners LLC (324K shares), BlueCrest Capital Management Ltd (230K shares), SG Americas Securities, LLC (202K shares), MORGAN STANLEY (174K shares), NATIXIS ADVISORS, L.P. (171K shares), DEUTSCHE BANK AG\ (140K shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (120K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.